Predicting who will transition from acute to chronic pain is the “holy grail” of pain neuroscience. A novel biomarker ...

If the drug is approved by the US Food and Drug Administration for the treatment of acute pain in January as expected, the ...

A novel biomarker signature combining PAF and CME predicts chronic pain risk, linking brain activity to individual pain ...

A network of nerves similar to wires runs all through the human body, from the tips of your fingers and toes, through your back inside the spinal cord and up to your brain. Specialized pain receptors ...

Published online in Neuron on January 13, the study fills a longstanding gap in understanding the origins of nociceptive-evoked GBOs and their selective relationship with pain processing across ...

A growing body of research suggests crabs, lobsters and other animals caught for seafood can feel pain. Scientists are pushing for legal protections to ensure they are treated humanely.

Christopher Groux is an editor, writer and accessibility advocate. Before joining the Forbes Health team, he covered Accessibility at Reviewed and gaming at Inverse and Newsweek. When he’s not ...

XG005 is a non-opioid, new chemical entity with dual mode of action in targeting both nociceptive and neuropathic pain signals. The placebo, 750 mg or 1250 mg of XG005, was administered orally ...

The first selective Fatty Acid Binding Protein 5 inhibitor safely administered to human subjectsInitial safety and pharmacokinetic data expected ...

How does your brain know when you feel pain? How does it know the difference between the soft touch of a feather and a needle prick? And, how does that information get to your body in time to respond?